IP Library Granted Patent US 10,709,461
Granted Patent B2
US 10,709,461 · App. 15/973,344 · Granted Jul 14, 2020

Subcutaneous wound debridement

Inventors: Jagjit Singh Gill (Rochester, MN); Lewis Hillel Freed (Scottsdale, AZ); Bernard Francis Morrey (Fayetteville, TX)
Assignee: Tenex Health, Inc.
A61B17/22012A61B17/320068A61B2217/005A61B2217/007
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,709,461
App. No.
15/973,344
Granted
Jul 14, 2020
Kind
B2
Abstract

Disclosed herein are devices and methods of percutaneously treating an ulcerated wound using ultrasonic energy. Some methods include delivering ultrasonic energy to a target tissue located at a position subcutaneous to the ulcerated wound. In some methods, the ultrasonic energy is delivered using an ultrasonic energy delivery device.

Claims (19)

1. A system for percutaneously treating an ulcerated wound by delivering ultrasonic energy to a target tissue located at a position subcutaneous to the ulcerated wound, wherein the ultrasonic energy is delivered using an ultrasonic energy delivery device, the device comprising: a transducer; an aspiration conduit; an irrigation conduit; and a needle; wherein, delivering ultrasonic energy to the target issue includes:

creating a plurality of percutaneous access portals surrounding the ulcerated wound in a cardinal orientation;

percutaneously inserting a distal portion of the needle to the position subcutaneous to the ulcerated wound using a first access portal of the plurality of access portals, generating ultrasonic energy at the subcutaneous position, and removing the distal portion of the needle from the first access portal; and

percutaneously inserting the distal portion of the needle to a second position subcutaneous to the ulcerated wound through a second access portal of the plurality of access portals, generating ultrasonic energy at the second subcutaneous position, and removing the distal portion of the needle from the second access portal.

2. The system of claim 1 , further comprising debriding the target tissue with the ultrasonic energy.

3. The system of claim 2 , further comprising removing from the subcutaneous position at least some detritus that may have been produced by the debriding.

4. The system of claim 1 , wherein the target tissue comprises at least one of the following: soft tissue and hard tissue.

5. The system of claim 1 , further comprising delivering fluid to the subcutaneous position.

6. The system of claim 1 , wherein the ultrasonic energy is delivered through the needle.

7. The system of claim 1 , wherein the ulcerated wound comprises a foot ulcer.

8. The system of claim 1 , wherein the target tissue located at the subcutaneous position comprises ulcerated wound tissue.

9. The system of claim 8 , wherein the ulcerated wound tissue comprises bone tissue.

10. The system of claim 8 , wherein the ulcerated wound tissue comprises abnormal growth.

11. The system of claim 10 , wherein the abnormal growth comprises at least one of a bony prominence, calcific tissue, and necrotic tissue.

12. The system of claim 1 , wherein the device further comprises a horn.

13. The system of claim 12 , wherein the needle comprises a stainless steel material, and wherein the needle is brazed to the horn.

14. The system of claim 1 , wherein the needle is a fully hardened hypodermic needle.

15. The system of claim 1 , wherein the needle includes an exposed portion having a length of about 0.75 inches to about 1.5 inches.

16. The system of claim 1 , wherein the needle has a gauge of about 12 to about 25.

Assignments (2)
SECURITY AGREEMENT Recorded Apr 1, 2021
From: TENEX HEALTH, INC.
To: AVENUE VENTURE OPPORTUNITIES FUND, LP
Reel/Frame 055811/0319 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 8, 2018
From: GILL, JAGJIT SINGH; FREED, LEWIS HILLEL; MORREY, BERNARD FRANCIS
To: TENEX HEALTH, INC.
Reel/Frame 045747/0251 →
Continuity (2)
Continuation 14475129 · Sep 2, 2014
Related Publication 20190125394A1 · May 2, 2019
Cited By (1)
US 12,667,377